TrialRadiation oncology (London, England)2014

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.

Zhengfei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.